CLASS II Drug recall · Reported 11 Oct 2023 · FDA Enforcement Report

fentaNYL, 2500 mcg/, (50 mcg/mL) Syringe recalled

Central Admixture Pharmacy Services is recalling fentaNYL, 2500 mcg/, (50 mcg/mL) Syringe, distributed nationwide in the US. The recall was initiated on 21 Sep 2023 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot:17-275464, Exp. 10/4/2023; 17-275850, Exp. 10/11/2023.
Quantity recalled476, 50 mL Syringes

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0021-2024
FDA event ID
93103
Recalling firm
Central Admixture Pharmacy Services, San Diego, CA
Classification
Class II
Status
Terminated
Recall initiated
21 Sep 2023
FDA classified
4 Oct 2023
Reported
11 Oct 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Sterility
Drug class
Pain Medication

Timeline

21 Sep 2023Recall initiated by company
4 Oct 2023Classified by FDA+13 days
11 Oct 2023Published in enforcement report+7 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Lack of assurance of sterility:

A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.

Product as listed by the FDA

fentaNYL, 2500 mcg/50 mL, (50 mcg/mL), 50 mL Syringe, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2003-3

Where it was distributed

Nationwide in the USA

Nationwide

Questions about this recall

Is fentaNYL, 2500 mcg/, (50 mcg/mL) Syringe recalled?

Yes. Central Admixture Pharmacy Services recalled fentaNYL, 2500 mcg/, (50 mcg/mL) Syringe on 21 Sep 2023. The recall is Class II and its status is Terminated. Recall number D-0021-2024.

Why was it recalled?

Lack of assurance of sterility:

Which lots are affected?

Lot:17-275464, Exp. 10/4/2023; 17-275850, Exp. 10/11/2023.

Where was it sold?

Nationwide in the USA

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Central Admixture Pharmacy Services

All 347